Johnson & Johnson stock is trading -8.62% below its average target price of $179.2 after marking a 3.3% during today's morning session. Analysts are giving the large-cap Pharmaceutical company an average rating of buy and target prices ranging from $161.0 to $215.0 per share.
The stock has a very low short interest at 0.4%, and a short ratio of 1.43. At 0.1%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that an average number of institutional investors are invested in the stock, with 71.7% of Johnson & Johnson's shares being owned by this investor type.
Institutions Invested in Johnson & Johnson
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2022-12-31 | Vanguard Group, Inc. (The) | 8% | 246,826,621 | $40,417,859,188 |
| 2022-12-31 | Blackrock Inc. | 6% | 198,802,769 | $32,553,953,423 |
| 2022-12-31 | State Street Corporation | 5% | 142,084,378 | $23,266,316,897 |
| 2022-12-31 | Geode Capital Management, LLC | 2% | 47,958,583 | $7,853,217,966 |
| 2022-12-31 | Morgan Stanley | 1% | 42,224,521 | $6,914,265,313 |
| 2022-12-31 | Northern Trust Corporation | 1% | 33,756,968 | $5,527,703,510 |
| 2022-12-31 | State Farm Mutual Automobile Insurance Co | 1% | 31,675,492 | $5,186,861,815 |
| 2022-12-31 | JP Morgan Chase & Company | 1% | 31,662,477 | $5,184,730,608 |
| 2022-12-31 | Bank of America Corporation | 1% | 31,111,148 | $5,094,450,485 |
| 2022-12-31 | Bank Of New York Mellon Corporation | 1% | 30,325,775 | $4,965,845,656 |
